NCIs FY95 Bypass To Justify $3.47 Billion, includes $490 million For Breast Cancer Research
In Brief: san Antonio’s ICRC Gets a New Name, SACI; Blum Is deputy Oncology Director At Kaplan
Who Writes NCI’s bypass Budget anyway>? Editor’s name Revealed
NCAB Votes To Return P01 Review To Pre-1987 System, Two-Tier Review
DCPC Advisors Consider Asking DRG For Section On Prevention & Control
Breast Cancer Coalition Plans Petition Urging Comprehensive Strategy
Low-Income Women Lack Mammography Access: Survey
Trending Stories
- Preparing to take care of each other in ways we never imagined
- 20 years of EGFR research: Ramalingam, Carbone, Politi, Jänne, Govindan reflect
- From the chairs of ECOG-ACRIN: A perspective on indirect costs
- On a new podcast, VCU’s Winn and City of Hope’s Carpten discuss the mission—and the future—of cancer centers
The Cancer Letter’s new podcast offers insight into cancer policy in a landscape of uncertainty - FDA grants Cytotron Breakthrough Device Designation for breast, liver and pancreatic cancers
- What Trump’s pick of RFK Jr. means for cancer: Epidemics, HPV, stunted research
Former FDA Commissioner Scott Gottlieb expresses “deep concerns”